The poster “Healthcare Resource Use and Treatment Patterns in Patients With Difficult-to-Treat Osteoarthritis in Sweden: Analyses From ‘BISCUITS’, a Large Nordic Observational Cohort Study”, co-authored by Quantify’s Johan Liseth Hansen, describes the treatment […]
An abstract co-authored by Quantify’s Emilie Toresson Grip, has been accepted for oral presentation at the European Society of Cardiology Heart Failure 2021 Online Congress in June. For this abstract, called “Empagliflozin use […]
The poster “Quality of Life in Patients with Osteoarthritis from Sweden; a Cohort Analysis from the ‘BISCUITS’ Study”, co-authored by Quantify’s Sara Hallberg, highlights the humanistic burden of #osteoarthritis (OA). With results showing that almost […]
Quantify’s Douglas Knutsson was interviewed by Life-time for having mapped the availability of 116 new medicines approved by the EMA in 2017-2019, on behalf of Lif – de forskande läkemedelsföretagen. The study covered […]
Everyone is affected by the ongoing pandemic, especially the most vulnerable of us. Therefore, Quantify has decided to make a donation to Majblomman, a nonprofit organisation with the mission to decrease the […]
Quantify’s Sara Hallberg, Emilie Toresson Grip & Johan Liseth Hansen are participating authors on the poster presenting one of the most comprehensive Nordic RWE studies on the economic burden of osteoarthritis conducted to date.
The BISCUITS study presented at ISPOREurope found […]
Last week we got to welcome another superstar to the team – Christoph Abé, our new Lead Analyst. Christoph has a PhD in biophysics and many years of experience within health care, psychiatry, and clinical research. He will strengthen our […]
Quantify’s Sara Hallberg, Emilie Toresson Grip & Anders Gustavsson are participating authors of one of the largest Nordic RWE studies on osteoarthritis (OA) conducted to date. The BISCUITS study includes all OA patients identified in specialist care in the Nordic countries, linking data on specialty and primary […]
Parkinson’s is a progressive incurable brain disease estimated to affect more than 10 million people worldwide. The disease affects physical movement, but it also exacts a social toll. Sufferers drop activities, relinquish […]
